TENAX THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
TENAX THERAPEUTICS, INC. (TENX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 20.58 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-29
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 25.26M shares, a 99.01% increase year-over-year.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 25.20M shares, a 102.79% increase year-over-year.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 17.22M shares, a 84.36% increase year-over-year.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 14.52M shares, a 108.12% increase year-over-year.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 20.58M shares, a 98.51% increase from fiscal 2020.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 10.37M shares, a 67.31% increase from fiscal 2019.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 6.20M shares, a 295.93% increase from fiscal 2018.
- TENAX THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 1.56M shares, a 10.93% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 8 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | 25.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 25.23M shares derived: average of 2 quarters · filed 2022-03-29 | 22.56M shares derived: average of 3 quarters · filed 2022-03-29 | 20.58M shares 10-K · filed 2022-03-29 | |||||
| 2021-09-30 | 25.20M shares 10-Q · filed 2021-11-15 | 21.21M shares derived: average of 2 quarters · filed 2021-11-15 | 19.02M shares 10-Q · filed 2021-11-15 | 17.41M shares derived: average of 4 quarters · filed 2022-03-29 | |||||
| 2021-06-30 | 17.22M shares 10-Q · filed 2021-08-16 | 15.87M shares 10-Q · filed 2021-08-16 | 14.81M shares derived: average of 3 quarters · filed 2022-03-29 | 14.21M shares derived: average of 4 quarters · filed 2022-03-29 | |||||
| 2021-03-31 | 14.52M shares 10-Q · filed 2021-05-17 | 13.60M shares derived: average of 2 quarters · filed 2022-03-29 | 13.21M shares derived: average of 3 quarters · filed 2022-03-29 | 12.24M shares derived: average of 4 quarters · filed 2022-03-29 | |||||
| 2020-12-31 | 12.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | 12.56M shares derived: average of 2 quarters · filed 2022-03-29 | 11.49M shares derived: average of 3 quarters · filed 2022-03-29 | 10.37M shares 10-K · filed 2022-03-29 | 7.42M shares 10-K · filed 2021-03-31 | ||||
| 2020-09-30 | 12.43M shares 10-Q · filed 2021-11-15 | 10.88M shares derived: average of 2 quarters · filed 2021-11-15 | 9.59M shares 10-Q · filed 2021-11-15 | 8.87M shares derived: average of 4 quarters · filed 2021-11-15 | |||||
| 2020-06-30 | 9.34M shares 10-Q · filed 2021-08-16 | 8.16M shares 10-Q · filed 2021-08-16 | 7.69M shares derived: average of 3 quarters · filed 2021-08-16 | 7.45M shares derived: average of 4 quarters · filed 2021-08-16 | |||||
| 2020-03-31 | 6.97M shares 10-Q · filed 2021-05-17 | 6.86M shares derived: average of 2 quarters · filed 2021-05-17 | 6.82M shares derived: average of 3 quarters · filed 2021-05-17 | 6.71M shares derived: average of 4 quarters · filed 2021-05-17 | |||||
| 2019-12-31 | 6.75M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | 6.74M shares derived: average of 2 quarters · filed 2021-04-16 | 6.62M shares derived: average of 3 quarters · filed 2021-04-16 | 6.20M shares 10-K/A · filed 2021-04-16 | |||||
| 2019-09-30 | 6.74M shares 10-Q · filed 2020-11-16 | 6.56M shares derived: average of 2 quarters · filed 2020-11-16 | 6.01M shares 10-Q · filed 2020-11-16 | 4.98M shares derived: average of 4 quarters · filed 2020-11-16 | |||||
| 2019-06-30 | 6.39M shares 10-Q · filed 2020-08-14 | 5.64M shares 10-Q · filed 2020-08-14 | 4.40M shares derived: average of 3 quarters · filed 2020-08-14 | 3.66M shares derived: average of 4 quarters · filed 2020-08-14 | |||||
| 2019-03-31 | 4.89M shares 10-Q · filed 2020-05-15 | 3.40M shares derived: average of 2 quarters · filed 2020-05-15 | 2.76M shares derived: average of 3 quarters · filed 2020-05-15 | 2.43M shares derived: average of 4 quarters · filed 2020-05-15 | |||||
| 2018-12-31 | 1.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 1.69M shares derived: average of 2 quarters · filed 2020-03-30 | 1.61M shares derived: average of 3 quarters · filed 2020-03-30 | 1.56M shares 10-K · filed 2020-03-30 | |||||
| 2018-09-30 | 1.46M shares 10-Q · filed 2019-11-14 | 1.46M shares derived: average of 2 quarters · filed 2019-11-14 | 1.45M shares 10-Q · filed 2019-11-14 | 1.44M shares derived: average of 4 quarters · filed 2019-11-14 | |||||
| 2018-06-30 | 1.45M shares 10-Q · filed 2019-08-14 | 1.44M shares 10-Q · filed 2019-08-14 | 1.43M shares derived: average of 3 quarters · filed 2019-08-14 | 1.43M shares derived: average of 4 quarters · filed 2019-08-14 | |||||
| 2018-03-31 | 1.42M shares 10-Q · filed 2019-05-15 | 1.42M shares derived: average of 2 quarters · filed 2019-05-15 | 1.42M shares derived: average of 3 quarters · filed 2019-05-15 | 1.41M shares derived: average of 4 quarters · filed 2019-05-15 | |||||
| 2017-12-31 | 1.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | 1.41M shares derived: average of 2 quarters · filed 2019-04-01 | 1.41M shares derived: average of 3 quarters · filed 2019-04-01 | 1.41M shares 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | 1.41M shares 10-Q · filed 2018-11-14 | 28.24M shares 10-Q · filed 2017-11-09 | 1.41M shares derived: average of 2 quarters · filed 2018-11-14 | 1.41M shares 10-Q · filed 2018-11-14 | 28.20M shares 10-Q · filed 2017-11-09 | -18.63M shares derived: average of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | 1.41M shares 10-Q · filed 2018-08-14 | 28.24M shares 10-Q · filed 2017-08-09 | 1.41M shares 10-Q · filed 2018-08-14 | 28.19M shares 10-Q · filed 2017-08-09 | -25.31M shares derived: average of 3 quarters · filed 2018-08-14 | -11.95M shares derived: average of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | 1.41M shares 10-Q · filed 2018-05-15 | 28.14M shares 10-Q · filed 2017-05-10 | -38.66M shares derived: average of 2 quarters · filed 2018-05-15 | -16.40M shares derived: average of 3 quarters · filed 2018-05-15 | -5.27M shares derived: average of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | -78.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -25.31M shares derived: average of 2 quarters · filed 2018-04-02 | -7.50M shares derived: average of 3 quarters · filed 2018-04-02 | 1.41M shares 10-K · filed 2018-04-02 | 28.12M shares 10-K · filed 2017-03-16 | ||||
| 2016-09-30 | 28.12M shares 10-Q · filed 2017-11-09 | 28.12M shares derived: average of 2 quarters · filed 2017-11-09 | 28.12M shares 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | 28.12M shares 10-Q · filed 2017-08-09 | 28.12M shares 10-Q · filed 2017-08-09 | |||||||
| 2016-03-31 | 28.12M shares 10-Q · filed 2017-05-10 | ||||||||
| 2015-12-31 | 28.12M shares 10-K · filed 2017-03-16 | ||||||||
| 2015-10-31 | 28.12M shares 10-Q · filed 2015-12-10 | 28.12M shares 10-Q · filed 2015-12-10 | |||||||
| 2015-09-30 | 28.12M shares 10-Q · filed 2016-11-09 | 28.12M shares 10-Q · filed 2016-11-09 | |||||||
| 2015-07-31 | 28.12M shares 10-Q · filed 2015-09-09 | ||||||||
| 2015-06-30 | 28.12M shares 10-Q · filed 2016-08-09 | 28.12M shares 10-Q · filed 2016-08-09 | |||||||
| 2015-04-30 | 28.08M shares 10-K · filed 2017-03-16 | ||||||||
| 2015-03-31 | 28.12M shares 10-Q · filed 2016-05-10 | ||||||||
| 2014-10-31 | 28.11M shares 10-Q · filed 2015-12-10 | 28.04M shares 10-Q · filed 2015-12-10 | |||||||
| 2014-07-31 | 27.66M shares 10-Q · filed 2015-09-09 | ||||||||
| 2014-04-30 | 9.36M shares 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |